InvestorsObserver
×
News Home

Should You Hold Rigel Pharmaceuticals, Inc. (RIGL) in Biotechnology Industry?

Monday, June 14, 2021 02:14 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Rigel Pharmaceuticals, Inc. (RIGL) in Biotechnology Industry?

The 61 rating InvestorsObserver gives to Rigel Pharmaceuticals, Inc. (RIGL) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 94 percent of stocks in the Biotechnology industry, RIGL’s 61 overall rating means the stock scores better than 61 percent of all stocks.

Overall Score - 61
RIGL has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on RIGL!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 61 would rank higher than 61 percent of all stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Rigel Pharmaceuticals, Inc. Stock Today?

Rigel Pharmaceuticals, Inc. (RIGL) stock is up 5.6% while the S&P 500 is lower by -0.27% as of 2:03 PM on Monday, Jun 14. RIGL has risen $0.22 from the previous closing price of $4.02 on volume of 1,608,269 shares. Over the past year the S&P 500 has risen 38.13% while RIGL has risen 128.49%. RIGL lost -$0.08 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Rigel Pharmaceuticals, Inc. (RIGL) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App